Senate LDA lobbying filing

CENCORA, INC.

Registrant: BROWNSTEIN HYATT FARBER SCHRECK, LLP Year: 2025 Period: First Quarter Type: Q1

View on lda.senate.gov ↗

Reported income

$60.0K

Reported expenses

not reported

Tracked program mentions1

Quoted activity text is clipped to a short extract; each filing’s full description is under Lobbying activities below.

Making, Maintaining, Supply Chain and Logistics0602025Ematched: “Supply|Chain”matched 2+ title words
IRA implementation. Drug Shortages; supply chain resiliency; PAHPA Reauthorization; Drug Supply Chain Security Act…

Lobbying activities2

Health IssuesHCR
IRA implementation. Drug Shortages; supply chain resiliency; PAHPA Reauthorization; Drug Supply Chain Security Act (DSCSA) Implementation, SUPPORT Act Reauthorization, Appropriations bills (FDA, Labor, HHS).
PharmacyPHA
Recognizing pharmacists as providers within Medicare; The Equitable Introduction of Community Access to Pharmacist Services Act Medicare reimbursement.

Lobbyists6

ADAM STEINMETZ
DEEMA TARAZI
EMILY FELDER
GREGORY SUNSTRUM
LAUREN MISH
ZACHARY PFISTER

Source: U.S. Senate Lobbying Disclosure Act database. Dollar figures (underlined) cite the filing record on lda.senate.gov — click to view the citation. Amounts shown as “not reported” are absent from the filing itself.